Widening the scope for the burden of COVID-19 - Comorbidities and long COVID: an analysis of the three pandemic years in Luxembourg.

S Schmitz, D Alvarez-Vaca, J Weiss, S M Pires, S Masi, M Debacker, A Alkerwi
{"title":"Widening the scope for the burden of COVID-19 - Comorbidities and long COVID: an analysis of the three pandemic years in Luxembourg.","authors":"S Schmitz, D Alvarez-Vaca, J Weiss, S M Pires, S Masi, M Debacker, A Alkerwi","doi":"10.26355/eurrev_202501_37058","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Burden of disease studies evaluate the direct impact of disease in terms of morbidity and premature mortality over a given time horizon. The objective of this study was to estimate the burden of COVID-19 in Luxembourg during the first three years of the pandemic, with a particular focus on methodologies applied to two areas of high uncertainty: post-acute consequences (PAC) of COVID-19 and the disparity of associated pathologies to COVID-19 deaths compared to other causes of deaths.</p><p><strong>Materials and methods: </strong>Epidemiological monitoring data on screening, hospital admission, and mortality associated with COVID-19 were used to estimate disability-adjusted life years (DALYs). Years of Life lost due to premature death (YLL) estimates have been adjusted for the impact of comorbidity profiles from cause-of-death data using the Charlson Comorbidity Index (CCI). In the absence of a PAC-specific disability weight, a symptom-based approach using data from a national cohort study was applied and compared with alternative weights used in the literature. A one-by-one sensitivity analysis was performed to evaluate the uncertainty associated with each model parameter.</p><p><strong>Results: </strong>The total burden of COVID-19, including PAC, over three years, was estimated at 17,801 DALYs, combining 14,903 YLLs and 2,898 YLDs (Years of Healthy Life lived with Disability). Comorbidity adjustment led to an average reduction of 9% in YLL estimates. Alternative choices for PAC led to an up to 3-fold increase in YLD compared to our base case estimates. Prevalence, disability weight, and duration of PAC were the most influential parameters identified in the sensitivity analysis.</p><p><strong>Conclusions: </strong>The COVID-19 pandemic has produced a significant burden on the resident population in Luxembourg. Adjusting for comorbidities is an important step in assessing the burden of COVID-19. The uncertainty associated with PAC parameters has highlighted the need for further research to standardize the definition of the prevalence, duration, and severity of this condition. The suggested symptom-based approach presents a flexible option until PAC-specific disability weights are derived in the future.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 1","pages":"39-52"},"PeriodicalIF":3.3000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European review for medical and pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26355/eurrev_202501_37058","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Burden of disease studies evaluate the direct impact of disease in terms of morbidity and premature mortality over a given time horizon. The objective of this study was to estimate the burden of COVID-19 in Luxembourg during the first three years of the pandemic, with a particular focus on methodologies applied to two areas of high uncertainty: post-acute consequences (PAC) of COVID-19 and the disparity of associated pathologies to COVID-19 deaths compared to other causes of deaths.

Materials and methods: Epidemiological monitoring data on screening, hospital admission, and mortality associated with COVID-19 were used to estimate disability-adjusted life years (DALYs). Years of Life lost due to premature death (YLL) estimates have been adjusted for the impact of comorbidity profiles from cause-of-death data using the Charlson Comorbidity Index (CCI). In the absence of a PAC-specific disability weight, a symptom-based approach using data from a national cohort study was applied and compared with alternative weights used in the literature. A one-by-one sensitivity analysis was performed to evaluate the uncertainty associated with each model parameter.

Results: The total burden of COVID-19, including PAC, over three years, was estimated at 17,801 DALYs, combining 14,903 YLLs and 2,898 YLDs (Years of Healthy Life lived with Disability). Comorbidity adjustment led to an average reduction of 9% in YLL estimates. Alternative choices for PAC led to an up to 3-fold increase in YLD compared to our base case estimates. Prevalence, disability weight, and duration of PAC were the most influential parameters identified in the sensitivity analysis.

Conclusions: The COVID-19 pandemic has produced a significant burden on the resident population in Luxembourg. Adjusting for comorbidities is an important step in assessing the burden of COVID-19. The uncertainty associated with PAC parameters has highlighted the need for further research to standardize the definition of the prevalence, duration, and severity of this condition. The suggested symptom-based approach presents a flexible option until PAC-specific disability weights are derived in the future.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.30
自引率
6.10%
发文量
906
审稿时长
2-4 weeks
期刊介绍: European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research. The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine. European Review for Medical and Pharmacological Sciences includes: -Editorials- Reviews- Original articles- Trials- Brief communications- Case reports (only if of particular interest and accompanied by a short review)
期刊最新文献
A novel description of AT deficiency in hospitalized COVID-19 patients. Association between exposure to pesticides and toxicity in humans: a review. Major predictive factors for recurrence of CIN after treatment: an exploratory analysis towards a predictive model. Prediction of phenotypes by secretory biomarkers and machine learning in patients with chronic rhinosinusitis. Widening the scope for the burden of COVID-19 - Comorbidities and long COVID: an analysis of the three pandemic years in Luxembourg.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1